Abstract:Background: The differentiation of pericytes into myofibroblasts causes microvascular degeneration, ECM (extracellular matrix) accumulation, and tissue stiffening, characteristics of fibrotic diseases. It is unclear how pericyte-myofibroblast differentiation is regulated in the microvascular environment. Our previous study established a novel 2-dimensional platform for coculturing microvascular endothelial cells (ECs) and pericytes derived from the same tissue. This study investigated how ECM stiffness regulated microvascular ECs, pericytes, and their interactions. Methods: Primary microvessels were cultured in the TGM2D medium (tubular microvascular growth medium on 2-dimensional substrates). Stiff ECM was prepared by incubating ECM solution in regular culture dishes for 1 hour followed by PBS wash. Soft ECM with Young modulus of ≈6 kPa was used unless otherwise noted. Bone grafts were prepared from the rat skull. Immunostaining, RNA sequencing, RT-qPCR (real-time quantitative polymerase chain reaction), Western blotting, and knockdown experiments were performed on the cells. Results: Primary microvascular pericytes differentiated into myofibroblasts (NG2+αSMA+) on stiff ECM, even with the TGFβ (transforming growth factor beta) signaling inhibitor A83-01. Soft ECM and A83-01 cooperatively maintained microvascular stability while inhibiting pericyte-myofibroblast differentiation (NG2+αSMA-/low). We thus defined 2 pericyte subpopulations: primary (NG2+αSMA-/low) and activated (NG2+αSMA+) pericytes. Soft ECM promoted microvascular regeneration and inhibited fibrosis in bone graft transplantation in vivo. As integrins are the major mechanosensor, we performed RT-qPCR screening of integrin family members and found Itgb1 (integrin β1) was the major subunit downregulated by soft ECM and A83-01 treatment. Knocking down Itgb1 suppressed myofibroblast differentiation on stiff ECM. Interestingly, ITGB1 phosphorylation (Y783) was mainly located on microvascular ECs on stiff ECM, which promoted EC secretion of paracrine factors, including CTGF (connective tissue growth factor), to induce pericyte-myofibroblast differentiation. CTGF knockdown or monoclonal antibody treatment partially reduced myofibroblast differentiation, implying the participation of multiple pathways in fibrosis formation. Conclusions: ECM stiffness and TGFβ signaling cooperatively regulate microvascular stability and pericyte-myofibroblast differentiation. Stiff ECM promotes EC ITGB1 phosphorylation (Y783) and CTGF secretion, which induces pericyte-myofibroblast differentiation.

Matrix stiffness regulates the triad communication of adipocytes/macrophages/endothelial cells through CXCL13

Regulating Osteogenesis and Adipogenesis in Adipose‐derived Stem Cells by Controlling Underlying Substrate Stiffness

Matrix Stiffness Exacerbates the Proinflammatory Responses of Vascular Smooth Muscle Cell Through the DDR1-DNMT1 Mechanotransduction Axis.

Extracellular Matrix Stiffness Regulates Microvascular Stability by Controlling Endothelial Paracrine Signaling to Determine Pericyte Fate

Modulation of Stiffness-Dependent Macrophage Inflammatory Responses by Collagen Deposition

Matrix stiffness regulates macrophage polarization in atherosclerosis

Relationship of Matrix Stiffness and Cell Morphology in Regulation of Osteo Genesis and Adipogenesis of BMSCs

Matrix Stiffness Regulates SMC Functions Via TGF-β Signaling Pathway

Matrix stiffness regulates the interactions between endothelial cells and monocytes.

Extracellular matrix with the rigidity of adipose tissue helps 3T3-L1 adipocytes maintain insulin responsiveness.

The role of matrix stiffness and viscosity on lipid phenotype and fat lineage potential

Matrix Stiffness Determines the Phenotype of Vascular Smooth Muscle Cell in Vitro and in Vivo: Role of DNA Methyltransferase 1

The Density of Extracellular Matrix Proteins Regulates Inflammation and Insulin Signaling in Adipocytes

Relationship of matrix stiffness and cell morphology in regulation of osteogenesis and adipogenesis of BMSCs

Increased Matrix Stiffness Promotes Fibrogenesis of Hepatic Stellate Cells Through AP-1-induced Chromatin Priming

Substrate Stiffness-Regulated Matrix Metalloproteinase Output in Myocardial Cells and Cardiac Fibroblasts: Implications for Myocardial Fibrosis.

Stiffness assisted cell-matrix remodeling trigger 3D mechanotransduction regulatory Programs to induce stem cell differentiation

3D matrix stiffness modulation unveils cardiac fibroblast phenotypic switching

Matrix Stiffness-Induced Transcriptome Alterations and Regulatory Mechanisms Revealed by RNA-Seq in Endothelial Cells

Matrix Stiffness Regulates the Immunomodulatory Effects of Mesenchymal Stem Cells on Macrophages Via AP1/TSG-6 Signaling Pathways.

Microenvironmental Stiffness Regulates Cellular Triglyceride Metabolism